Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 16 entities : Bristol-myers squibb company save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Published: 2021-04-16 (Crawled : 19:00) - biospace.com/
BMY | $48.64 -0.71% 2.3M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
food therapy cancer drug nivolumab
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Published: 2021-04-16 (Crawled : 18:04) - fda.gov
BMY | $48.64 -0.71% 2.3M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
cancer fda fda approval approval nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-16 (Crawled : 18:04) - fda.gov
PFE | News 4 | $26.185 -0.51% 6.6M
|
Health Technology
|
| O: 0.72%
H: 2.19%
C: 1.85%
LLY | News | $731.46 -1.91% 700K
|
Health Technology
|
| O: 0.79%
H: 1.56%
C: 1.0%
BMY | $48.64 -0.71% 2.3M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
ABBV | News | $168.1 -0.85% 670K
|
Health Technology
|
| O: 0.56%
H: 0.99%
C: 0.39%
YMAB | $15.12 -1.43% 35K
|
Health Technology
|
| O: 1.5%
H: 0.22%
C: -5.38%
VSTM | $9.385 -2.34% 15K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -1.47%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: 0.59%
H: 0.96%
C: 0.61%
RIGL | $1.135 -0.44% 150K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: -5.54%
REGN | News | $911.73 0.49% 97K
|
Health Technology
|
| O: 0.41%
H: 2.06%
C: 1.2%
KPTI | $1.08 -0.92% 350K
|
Health Technology
|
| O: -0.26%
H: 2.95%
C: 0.47%
INCY | $51.27 -0.74% 170K
|
Health Technology
|
| O: 0.5%
H: 0.3%
C: -1.12%
ILMN | $121.115 -2.69% 160K
|
Health Technology
|
| O: -0.02%
H: 0.12%
C: -0.72%
EXEL | $23.525 1.01% 310K
|
Health Technology
|
| O: -0.17%
H: 0.84%
C: -1.34%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.97%
H: 0.24%
C: -2.59%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.66%
H: 1.16%
C: -1.32%
BPMC | $92.65 0.39% 99K
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: -1.92%
BGNE | $143.42 3.19% 69K
|
Health Technology
|
| O: -0.07%
H: 0.18%
C: -0.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.95%
H: 0.16%
C: -0.48%
AMGN | News | $273.6 0.02% 370K
|
Health Technology
|
| O: 0.51%
H: 0.93%
C: -0.28%
ALNY | $144.215 -1.27% 110K
|
Health Technology
|
| O: 0.41%
H: 0.34%
C: -0.51%
AGIO | $31.57 -0.75% 100K
|
Health Technology
|
| O: -0.45%
H: 2.17%
C: -0.18%
cancer approval
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Published: 2021-04-16 (Crawled : 17:00) - fda.gov
BMY | $48.64 -0.71% 2.3M
|
Health Technology
|
| O: 0.76%
H: 1.09%
C: 0.82%
cancer treatment fda approval fda approval immunotherapy
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.